Sponsor Pipeline

Newish Biotech (Wuxi) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
4
Recruiting
Active Trials by Phase
Phase 2
2
Phase 1/2
1
Phase 1
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07175662 Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL High-grade Squamous Intraepithelial Lesion (HSIL) Recruiting
NCT07712692 Evaluation of NWRD09 for HPV-16 Related Cervical HSIL High-grade Squamous Intraepithelial Lesion (HSIL) Not Yet Recruiting
Phase 1/2
NCT07536282 Evaluation of NWRD09 for Female Participants With Persistent HPV16 Infection Persistent HPV16 Infection Not Yet Recruiting
Phase 1
NCT07047989 NWRD09 for HPV-16 Related Cervical HSIL High-grade Squamous Intraepithelial Lesion (HSIL) Recruiting
NCT07710664 A Study of NWRD09 in Participants With Persistent HPV16 Infection in the Anal Region Persistent HPV16 Infection Recruiting
Not specified
NCT07710703 NWRD09 for Persistent Cervical HPV16 Infection Persistent Cervical HPV16 Infection Recruiting
Get alerts when Newish Biotech (Wuxi) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free